246 related articles for article (PubMed ID: 34951580)
1. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer.
Wang Z; Cui Q; Shi L; Zhang M; Song P; Duan D; Guo W
Recent Pat Anticancer Drug Discov; 2022; 17(3):297-311. PubMed ID: 34951580
[TBL] [Abstract][Full Text] [Related]
2. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
3. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
6. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
[TBL] [Abstract][Full Text] [Related]
8. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
9. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification].
Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910
[TBL] [Abstract][Full Text] [Related]
11. Exploring the mechanism of Erteng-Sanjie capsule in treating gastric and colorectal cancers via network pharmacology and in-vivo validation.
Zhang W; Wang Y; Yu H; Jin Z; Yuan Y; Liu L; Zhou J
J Ethnopharmacol; 2024 Jun; 327():117945. PubMed ID: 38428659
[TBL] [Abstract][Full Text] [Related]
12. Exploring the pharmacological and molecular mechanisms of Salvia chinensis Benth in colorectal cancer: A network pharmacology and molecular docking study.
Zheng Q; Wang X; Gao T; Zhang B; Zhao N; Du R; Zhao Z
Medicine (Baltimore); 2023 Dec; 102(50):e36602. PubMed ID: 38115259
[TBL] [Abstract][Full Text] [Related]
13. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology.
Wang S; Gao J; Li Q; Ming W; Fu Y; Song L; Qin J
J Ethnopharmacol; 2020 Nov; 262():113189. PubMed ID: 32736044
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of astragaloside Ⅳ alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments].
Zhang TQ; Li CC; Zhang TF; Wang MY; Cui SN; Huo Q
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6465-6473. PubMed ID: 34994139
[TBL] [Abstract][Full Text] [Related]
15. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation.
Shang L; Wang Y; Li J; Zhou F; Xiao K; Liu Y; Zhang M; Wang S; Yang S
J Ethnopharmacol; 2023 Feb; 302(Pt A):115876. PubMed ID: 36343798
[TBL] [Abstract][Full Text] [Related]
17. The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction.
Guo JF; Zhao YT; Du QY; Ren Y; Wang Y; Wang ZX; Jin W
Biomed Res Int; 2022; 2022():2775434. PubMed ID: 35528155
[TBL] [Abstract][Full Text] [Related]
18. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology and molecular docking study on the effect of Kaempferol in treatment of metabolic associated fatty liver disease.
Kaixuan Z; Dong Z; Huiwei B; Lijing LI
J Tradit Chin Med; 2022 Oct; 42(5):788-794. PubMed ID: 36083487
[TBL] [Abstract][Full Text] [Related]
20. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
